Processa Pharmaceuticals PCSA 深 沪
等待开盘 11-11 09:30:00 美东时间
0.3281
+0.022
+7.29%
华盛通- 最 高0.3389
- 今 开0.32
- 成交量 176.31万股
- 最 低 0.3154
- 昨 收 0.3058
- 总市值 1651.95万
- 52周最高 1.50
- 市盈率 静 --
- 换手率 3.50%
- 52周最低 0.15
- 委 比 0.00%
- 总股本 5034.91万
- 历史最高 284.80
- 量 比 0.97
- 振 幅 7.68%
- 历史最低 0.15
- 每 手 1
- 风险率 0.30%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Processa Pharma's Abstract, "Adaptive Phase 2/3 Study For PCS499 (499) In Patients With Focal Segmental Glomerulosclerosis (FSGS)", Accepted For Presentation At ASN Kidney Week 2025
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies and innovative treatments for rare diseases, today announced that its
11-05 22:16
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Replimune Group (NASDAQ:REPL) stock increased by 95.3% to $8.79 during...
10-20 20:08
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares rose 113.4% to $3.99 during T...
10-09 20:07
Processa Pharmaceuticals shares are trading higher. The stock has recently gained social media buzz.
Processa Pharmaceuticals shares are trading higher. The stock has recently gain...
10-09 00:56
Why Processa Pharmaceuticals Stock Rose Almost 38% Overnight?
Processa Pharmaceuticals shares jumped 37.5% after hours following a strong regular session, despite facing significant losses over the past year.
10-08 15:40
Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket
Shares of Telomir Pharmaceuticals Inc (NASDAQ:TELO) rose sharply in pre-market ...
10-07 17:28
Processa Pharmaceuticals Reschedules Special Shareholder Meeting
Processa Pharmaceuticals ( ($PCSA) ) has issued an announcement. On September 2...
09-10 22:59
Processa Pharmaceuticals Adjourns Special Shareholder Meeting
Processa Pharmaceuticals ( ($PCSA) ) has shared an announcement. On September 2...
09-03 05:27
HC Wainwright & Co. Maintains Buy on Processa Pharmaceuticals, Lowers Price Target to $1
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Processa Pharmaceuticals (NASDAQ:PCSA) with a Buy and lowers the price target from $2 to $1.
09-02 19:18
Processa Pharmaceuticals Relocates 2025 Stockholder Meeting
Processa Pharmaceuticals ( ($PCSA) ) has issued an announcement. On August 25, ...
08-26 05:48
